These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38112634)
1. A comprehensive analysis of the prognostic and immunotherapeutic characteristics of KIFC1 in pan-cancer and its role in the malignant phenotype of pancreatic cancer. Zhang S; Qin O; Xu H; Wu S; Huang W; Song H Aging (Albany NY); 2023 Dec; 15(24):14845-14863. PubMed ID: 38112634 [TBL] [Abstract][Full Text] [Related]
2. Expression of kinesin family member C1 in pancreatic ductal adenocarcinoma affects tumor progression and stemness. Ishikawa A; Fujii H; Fukui T; Kido A; Katsuya N; Sentani K; Kuraoka K; Tazuma S; Sudo T; Serikawa M; Oka S; Oue N Pathol Res Pract; 2023 Jan; 241():154277. PubMed ID: 36565617 [TBL] [Abstract][Full Text] [Related]
3. An Integrative Pan-Cancer Analysis of Kinesin Family Member C1 (KIFC1) in Human Tumors. Wu H; Duan Y; Gong S; Zhu Q; Liu X; Liu Z Biomedicines; 2022 Mar; 10(3):. PubMed ID: 35327439 [TBL] [Abstract][Full Text] [Related]
4. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas. Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J Front Immunol; 2022; 13():849592. PubMed ID: 35444654 [TBL] [Abstract][Full Text] [Related]
5. The Roles of KIFC1 in the Development of Osteosarcoma: Characterization of Potential Therapeutic Targets. Liang LY; Li GS Comput Math Methods Med; 2022; 2022():5039134. PubMed ID: 35479190 [TBL] [Abstract][Full Text] [Related]
6. High KIFC1 expression is associated with poor prognosis in prostate cancer. Kostecka LG; Olseen A; Kang K; Torga G; Pienta KJ; Amend SR Med Oncol; 2021 Mar; 38(5):47. PubMed ID: 33760984 [TBL] [Abstract][Full Text] [Related]
7. Kinesin family member C1 accelerates bladder cancer cell proliferation and induces epithelial-mesenchymal transition via Akt/GSK3β signaling. Xiao KH; Teng K; Ye YL; Tan L; Chen MK; Liang HT; Feng ZH; Duan JL; Deng MH; Wei WS; Luo JH; Qin ZK; Xie D Cancer Sci; 2019 Sep; 110(9):2822-2833. PubMed ID: 31278883 [TBL] [Abstract][Full Text] [Related]
8. Kinesin Family Member C1 Overexpression Exerts Tumor-Promoting Properties in Head and Neck Squamous Cell Carcinoma via the Rac1/Wnt/β-catenin Pathway. Yu BY; Shi LG; Jiang C; Wang GK; Liu J; Wu TY Lab Invest; 2023 Jul; 103(7):100134. PubMed ID: 36990154 [TBL] [Abstract][Full Text] [Related]
9. Increased expression levels of AURKA and KIFC1 are promising predictors of progression and poor survival associated with gastric cancer. Jung J; Jeong H; Choi JW; Kim HS; Oh HE; Lee ES; Kim YS; Lee JH Pathol Res Pract; 2021 Aug; 224():153524. PubMed ID: 34148003 [TBL] [Abstract][Full Text] [Related]
10. Kinesin Family Member C1 (KIFC1) Accelerates Proliferation and Invasion of Endometrial Cancer Cells Through Modulating the PI3K/AKT Signaling Pathway. Zhou K; Zhao J; Qi L; He Y; Xu J; Dai M Technol Cancer Res Treat; 2020; 19():1533033820964217. PubMed ID: 33034273 [TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of kinesin family member C1 in various cancers: A meta-analysis. Sun Y; Zhang Y; Lang Z; Huang J; Zou Z Medicine (Baltimore); 2019 Oct; 98(40):e17346. PubMed ID: 31577729 [TBL] [Abstract][Full Text] [Related]
13. Kinesin Family Member C1 Increases Temozolomide Resistance of Glioblastoma Through Promoting DNA Damage Repair. Wu J; Wang X; Yuan X; Shan Q; Wang Z; Wu Y; Xie J Cell Transplant; 2021; 30():963689721991466. PubMed ID: 33588605 [TBL] [Abstract][Full Text] [Related]
14. KIFC1, a novel potential prognostic factor and therapeutic target in hepatocellular carcinoma. Fu X; Zhu Y; Zheng B; Zou Y; Wang C; Wu P; Wang J; Chen H; Du P; Liang B; Fang L Int J Oncol; 2018 Jun; 52(6):1912-1922. PubMed ID: 29620256 [TBL] [Abstract][Full Text] [Related]
15. High Expression of KIFC1 in Glioma Correlates with Poor Prognosis. Xue P; Zheng J; Li R; Yan L; Wang Z; Jia Q; Zhang L; Li X J Korean Neurosurg Soc; 2024 May; 67(3):364-375. PubMed ID: 38720546 [TBL] [Abstract][Full Text] [Related]
16. Kinesin Family Member C1: Function in liver hepatocellular carcinoma and potential target for chemotherapeutic. Liu L; Jing F; Li J; Gong P; Shi B; Zhu Y; Yu H Heliyon; 2024 Sep; 10(18):e37832. PubMed ID: 39315235 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value and Immunological Role of KIFC1 in Hepatocellular Carcinoma. Li D; Yu T; Han J; Xu X; Wu J; Song W; Liu G; Zhu H; Zeng Z Front Mol Biosci; 2021; 8():799651. PubMed ID: 35111813 [TBL] [Abstract][Full Text] [Related]
18. Kinesin Family Member C1 (KIFC1/HSET) Underlies Aggressive Disease in Androgen Receptor-Low and Basal-Like Triple-Negative Breast Cancers. Jinna N; Yuan YC; Rida P Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003261 [TBL] [Abstract][Full Text] [Related]
19. Kinesin Family Member C1 (KIFC1) Regulated by Centrosome Protein E (CENPE) Promotes Proliferation, Migration, and Epithelial-Mesenchymal Transition of Ovarian Cancer. Li J; Diao H; Guan X; Tian X Med Sci Monit; 2020 Dec; 26():e927869. PubMed ID: 33361741 [TBL] [Abstract][Full Text] [Related]
20. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity. Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]